Anti-ulcer potential of flavonoids

Indian Journal of Physiology and Pharmacology

Volumn 42, Issue 3, 1998, Pages 343-351

  Parmar, N S ^a   Parmar, Shikha ^b  

^a K B INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH   (India)

^b L M COLLEGE OF PHARMACY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ASCORBIC ACID; AURANTIIN; CATECHIN; CHALCONE DERIVATIVE; FLAVONOID; GOSSYPINE; HISTIDINE DECARBOXYLASE; INDOMETACIN; KAEMPFEROL; MECIADANOL; MONOXERUTIN; NARINGENIN; NOBILETIN; PHENYLBUTAZONE; RESERPINE; RUTOSIDE; SOFALCONE;

CELL PROTECTION; DRUG EFFICACY; DUODENUM ULCER; HEMOLYTIC ANEMIA; HUMAN; MEMBRANE STRUCTURE; NONHUMAN; PEPTIC ULCER; REVIEW; STOMACH ULCER;

ANTI-ULCER AGENTS; CATECHIN; CHALCONE; CHALCONES; FLAVONOIDS; HUMANS; PEPTIC ULCER; PLANTS;

EID: 0031657630     PISSN: 00195499     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (51)

1. Middleton E Jr. The flavonoids. TIPS 1984; 335-338.
2. Robbins RC. Action in human blood of methoxylated flavones which confer disease resistance on both plants and animals. Concept of a dietary conditional mechanism of defence against disease. Int J Vit Nutr Res 1975; 45: 51-60.
3. Mason P. Diet and coronay heart disease - an update. Pharm J 1997; 258: 170-173.
4. Vogin EE, Rossi GV. Bioflavonoids in experimental ulceration. J Amer Pharm Assoc Sci Edn 1961; 50: 14-17.
5. Recchia F, Angelini F. Aggiorn. Pediat. 1954; 5: 605-625. Quoted by H. K. Von Rechenberg (1962) In Phenylbutazone pp. 56, London : Edward Arnold (Publishers) Ltd.
6. Recchia F, Angelini F. Aggiorn. Pediat. 1954; 5: 605-625. Quoted by H. K. Von Rechenberg (1962) In Phenylbutazone pp. 56, London : Edward Arnold (Publishers) Ltd.
7. Ciaceri G, Attaguile G. Results with luteolin, apigenin and acacetin in experimentally induced gastric ulcer. Minerva Med 1972; 63: 1605.
8. Parmar NS. A pharmacological study on the effects of some bioflavonoids on experimentally induced inflammation, increased vascular permeability, gastric ulcers and galactosemic cataracts. Ph.D. Thesis, University of Madras India, 1977.
9. Reimann HJ, Lorenz W, Fischer M, Frolich R, Meyer HJ. Histamine and acute hemorrhagic lesions in rat gastric mucosa : Prevention of stress ulcer formation by (+)-catechin, an inhibitor of specific histidine decarbocylase in vitro. Agents and Actions 1977; 7: 69-72.
10. Levine RJ, Senay EC. Histamine in pathogenesis of stress ulcer in the rat. Am J Physiol 1968; 214: 892-896.
11. Lorenz W, Kusche J, Barth H, Mathias CH. Action of several flavonoids on enzyme of histidine metabolism in vitro. In Histamine pp. 265-269 (Ed. Cz. Maslinski) Dowden, Hutchinson and Ross, Stroudsberg, Pennsylvania, 1973.
12. Parmar NS, Ghosh MN. Gastric anti-ulcer activity of (+)-cyanidanol-3, a histidine decarboxylase inhibitor. Eur J Pharmac 1981; 69: 25-32.
13. Wendt P, Reimann HJ, Swoboda K, Hennings G, Blumen G. The use of flavonoids as inhibitors of histidine decarboxylase in gastric disease, Experimental and clinical studies. Naunyn-Schmiedeberg's Arch Pharma Suppl 1980; 313: 218.
14. Ritchie WP, Breen JJ Jr, Griggs DI. Prevention of stress ulcer by reducing gastric tissue histamine. Surgery 1967; 62: 590-600.
15. Albertani, Borowski N. 3-Methoxy-5, 7, 3',4'-tetrahydroxyflavan. Drugs of the Future 1983; 8: 209.
16. Hackett AM, Griffiths LA. The metabolism and excretion of 3-O-methyl-(+)-catechin in the rat mouse and marmoset. Drug Metabolism and Excretion 1981; 9: 54-58.
17. Griffits LA. Topics in Flavonoid Chemistry and Biochemistry. p.201 (Eds. L. Farakas, M. Gabor, and F. Kally) Elsevier, Amsterdam, 1975.
18. Parmar NS, Ghosh MN. Gastric anti-ulcer activity of 3-O-methyl-(+)-catechin. In Studies in Organic Chemistry, Vol. 11, pp. 513-521 (Eds F. Farakas, Gabor, M., Kallay, F. and Wagner, H.) Elsevier, Amsterdam 1982.
19. Parmar NS, Hennings G. The effect of 3-methoxy-5, 7, 3',4]-tetrahydroxyflavan on the restraint induced gastric ulceration augmented by aspirin, a gastric mucosal barrier breaker. Res Comm Chem Path & Pharmac 1983; 41: 337-340.
20. Parmar NS, Hennings G. The gastric anti-secretory activity of 3-methoxy-5, 7, 3',4'-tetrahydroxyflavan, a specific histidine decarboxylase inhibitor in rats. Agents and Actions 1984; 15: 143-145.
21. Albinus N, Frisch G, Hennings G. Histidine decarboxylase inhibition by O-methyl-3-(+)-catechin and gastric acid secretion in the cat. Agents and Actions 1983; 13: 249-251.
22. Parmar NS, Hennings G. Effect of 3-methoxy-5, 7, 3', 4'-tetrahydroxyflavan on the healing of restraint ulcers in albino rats. IRCS Med Sci 1984; 12: 393-394.
23. Parmar NS, Hennings G, Gulati OP. Histidine decarboxylase inhibition : A novel approach towards the development of an effective and safe gastric anti-ulcer drug. Agents and Actions 1984; 15: 494-499.
24. Ganote DP, Hennings G, Lucker PW. 3-Methoxy-5, 7, 3', 4'-tetrahdroxyflavan, a new compound to prevent gastric irritation. A gastric potential difference analysis. Meth and Find Exptl Clin Pharmacol 1983; 5: 489-494.
25. Laule H, Lucker PW, Altmayar P, Eldon MA. Gastric potential difference as a model in clinical pharmacology: assessment of gastric mucosal response to aspirin. Eur J Clin Pharmacol 1982; 22: 147-151.
26. Konturek SJ, Kitler ME, Kwiecien N, Obtulowicz W, Oleksy T, Kopp B. Effect of meciadanol on gastric secretion and aspirin induced gastric mucosal injury in humans. Scand J Gastroenterol 1984; 19: 1099-1103.
27. Konturk SJ, Kitler ME, Brzozowksi T, Radecki T. Gastric protection by meciadanol. A new synthetic flavonoid - inhibiting histidine decarboxylase. Dig Dis Sci 1986; 31: 847-852.
28. +-ATPase inhibition by catechins. J Pharm Pharmacol 1992; 44: 926-928.
29. Alarcon de la Lastra C, Martin MJ, Marhuenda E. Gastric anti-ulcer activity of silymarin, a lipoxygenase inhibitor in rats. J Pharm Pharmacol 1992; 44: 929-931.
30. Izzo AA, Dicarlo G, Mascolo N, Capasso F, Autore G. Anti-ulcer effect of flavonoids. Role of endogenous PAF. Phytotherapy Res 1994; 8: 179-181.
31. Konturek SJ, Radecki T, Brozozowski T, Drozdowicz D, Piastucki I, Muramatsu M, Tanaka M, Aihara H. Anti-ulcer and gastroprotective effects of solon, a synthetic flavonoid derivative of sophoradin. Role of endogenous prostaglandins. Eur J Pharmac 1986; 125: 185-192.
32. Suwa T, Nakajima M, Shinozaki A, Kyogoku K, Mori Y. Cytoprotective effect of SU-88, an anti-ulcer agent in the rat. Japan J Pharmacol 1983; 35: 47-53.
33. Saziki R, Arai I, Isobe Y, Hirose H, Aihara H. Effect of sofalcone on necrotizing agents-induced gastric lesions and endogenous prostaglandins in rat stomachs. J Pharm Dyn 1984; 7: 791-797.
34. Muramatsu M, Tanaka M, Murakami S, Aihara H. Effect of sofalcone on gastric mucosal prostaglandin metabolism in taurocholate induce gastritis in rats. Res Comm Chem Path & Pharmacol 1986; 53: 289-300.
35. Nomura K, Iwama T, Honda K, Murata M. Chemical evaluation of SU-88 against gastric ulcer. Long term study. Japan Pharmacol Ther 1982; 10: 1.
36. Hirasawa T, Shoji T, Hoshino E, Saito Y, Okamoto H, Anno E, Endo K, Sizuki A. Clinical study of effect of SU-88 on gastric ulcer combination of treatment. Japan Pharmacol Ther 1982; 10: 5.
37. Gomi K, Kwayama H, Abe M, Okada S, Tanaka S, Tanaka Y. Clinical evaluation of SU-88 on peptic ulcer. Japan Pharmacol Ther 1982; 10: 1.
38. Sankawa U. In Proceedings of the Seventh Asian Symposium on Medicinal Plants, Spices and other Natural Products, Eds. Cruz, L. J., Concepcion, G. P., Mendigo, M. A. S. and Guevara, B. Q. University of Philippines, Manila, 1992, p. 143.
39. Yamamoto K, Kakegawa H, Ueda H, Matsumoto H, Sudo T, Miki T, Satoh T. Gastric cytoprotective and anti-ulcerogenic actions of hydroxychalcones in rats. Planta Med 1992; 58: 389-393.
40. Kyogoku K, Hatayama K, Yokamori, Saziki R, Nakane S, Sasajima M, Sawada J, Ohzeki M, Tanaka I. Anti-ulcer effect of isoprenyl flavonoids. Synthesis and anti-ulcer activity of new chalcones related to sophoradin. Chem Pharm Bull 1979; 27: 2943.
41. Goel RK, Pandey VB, Dwivedi SPD, Rao YV. Anti-inflammatory and anti-ulcer effects of kaempferol, a flavone, isolated from Rhamnus procumbens. Ind J Exp Biol 1988; 26: 121-124.
42. Ruiz MR, Martin-Cordero C, Gonzalez MJA, Toro-Sainz M V, Aracon de la Lastra C. Anti-ulcer activity in rats by flavonoids of Erica andevalensis Carbezudo-Rivera. Phytotherapy Res 1996; 10: 300-303.
43. Gambhir SS, Goel RK, Dasgupta G. Anti-inflammatory and anti-ulcerogenic activity of amentoflavone. Ind J Med Res 1987; 85: 689-693.
44. Goel RK, Gambhir SS, Dasgupta G. Mechanism of anti-ulcerogenic effect of amentoflavone. Ind J Med Res 1988; 88: 192-196.
45. Rainova I, Nakov N, Bogdanova S, Minkova E, Taneva-Stoytcheva D. Ulceroprotective activity of the flavonoids of Genista rumelica Vel. PhytotherapyRes 1988; 2: 137-139.
46. Alcaraz MJ Tordera M. Studies on the gastric anti-ulcer activity of hypolaetin-8-glucoside. Phytotherapy Res 1988; 2: 85-88.
47. Parmar NS. The gastric anti-ulcer activity of naringenin, a specific histidine decarboxylase inhibitor. Intl Jour Tissue Reac 1983; 4: 415-420.
48. Martin M J, Motilva V, Alarcon de laLastra C. Quercetin and Naringenin : Effect on ulcer formation and gastric secretion in rats. Phytotherapy Res 1993: 7: 150-153.
49. Takase H, Yamamoto K, Hirano H, Saito Y, Yamashita A. Pharmacological profile of gastric mucosal protection by marmin and nobiletin from a traditional herbal medicine - Aurantii fractus immaturus. Jap J Pharmacol 1994; 66: 139-147.
50. Alarcon de la Lastra C, Lopez A, Motilva V. Gastroprotection and prostagland in E2 generation in rats by flavonoids of Dittrichia viscosa. Planta Med 1993; 59: 497-501.
51. Attaguile G, Caruso A, Pennisi G, Savoca F. Gastroprotective effect of aqueous extract of Cistus incanus L. in rats. Pharmacol Res 1995; 31: 29-32.